ZENEUS PHARMA LIMITED – Trademark Portfolio

Entity Type: 11

ZENEUS PHARMA LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. The owner is based in Oxford.

The Magdalen Centre

Oxford OX4 4GA , GB

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZENEUS
ZENEUS
Abandoned 2004
MYOCET
MYOCET
Cancelled 2002

Trademark Classifications

ZENEUS PHARMA LIMITED's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ZENEUS PHARMA LIMITED have?

ZENEUS PHARMA LIMITED has 2 U.S. trademarks filed with the USPTO.

What trademark classes does ZENEUS PHARMA LIMITED file in?

ZENEUS PHARMA LIMITED files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is ZENEUS PHARMA LIMITED's trademark registration success rate?

ZENEUS PHARMA LIMITED has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.